CRSP Stockholders Equity
Crispr Therapeutics Ag · Stockholders Equity
CRSP Stockholders Equity
Latest reported$1.92Bperiod ending
CRSP FY Shareholders Equity (-$7.12M → $1.92B)
Annual shareholders equity
High-resolution chart · PNG
CRSP stockholders equity history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stockholders Equity (USD) |
|---|---|
| 1,921,813,000 | |
| 1,932,080,000 | |
| 1,882,803,000 | |
| 1,875,479,000 | |
| 2,399,460,000 | |
| 1,664,234,000 | |
| 939,425,000 | |
| 392,195,000 | |
| 187,832,000 | |
| 232,846,000 | |
| -29,097,000 | |
| -7,117,000 |